www.reuters.com Open in urlscan Pro
2600:9000:21b8:6400:15:5a3e:9d40:93a1  Public Scan

URL: https://www.reuters.com/business/healthcare-pharmaceuticals/blood-your-hands-if-world-steps-back-tackling-covid-now-who-...
Submission: On December 06 via api from US — Scanned from US

Form analysis 0 forms found in the DOM

Text Content

Skip to main content
Report this ad
Exclusive news, data and analytics for financial market professionalsLearn more
aboutRefinitiv

 * World
   Browse World
    * Africa
    * Americas
    * Asia Pacific
    * China
    * Europe
    * India
    * Israel and Hamas at War
   
    * Japan
    * Middle East
    * Ukraine and Russia at War
    * United Kingdom
    * United States
    * Reuters NEXT

 * Business
   Browse Business
    * Aerospace & Defense
    * Autos & Transportation
    * Davos
    * Energy
    * Environment
    * Finance
    * Healthcare & Pharmaceuticals
   
    * Media & Telecom
    * Retail & Consumer
    * Future of Health
    * Future of Money
    * Take Five
    * World at Work

 * Markets
   Browse Markets
    * Asian Markets
    * Carbon Markets
    * Commodities
    * Currencies
    * Deals
    * Emerging Markets
    * ETFs
    * European Markets
   
    * Funds
    * Global Market Data
    * Rates & Bonds
    * Stocks
    * U.S. Markets
    * Wealth
    * Macro Matters

 * Sustainability
   Browse Sustainability
    * Boards, Policy & Regulation
    * Climate & Energy
    * Land Use & Biodiversity
    * Society & Equity
   
    * Sustainable Finance & Reporting
    * The Switch
    * Reuters Impact
    * COP29

 * Legal
   Browse Legal
    * Government
    * Legal Industry
    * Litigation
    * Transactional
    * US Supreme Court

 * Breakingviews
   Browse Breakingviews
    * Breakingviews Predictions

 * Technology
   Browse Technology
    * Artificial Intelligence
    * Cybersecurity
    * Space
    * Disrupted

 * Investigations
 * More
   Sports
    * Athletics
    * Baseball
    * Basketball
    * Cricket
    * Cycling
    * Formula 1
    * Golf
    * NFL
    * NHL
    * Soccer
    * Tennis
   
   Science
   Lifestyle
   Graphics
   Pictures
   Wider Image
   Podcasts
   Fact Check
   Video
   Sponsored Content
    * Reuters Plus
    * Press Releases
   
   Live

My News

Sign InSubscribe

Healthcare & Pharmaceuticals


'BLOOD ON YOUR HANDS' IF WORLD STEPS BACK ON TACKLING COVID NOW, WHO OFFICIAL
SAYS

By Jennifer Rigby
September 23, 20228:17 AM HSTUpdated 2 years ago
Text
 * Small Text
 * Medium Text
 * Large Text

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

Bruce Aylward, Senior Advisor to the Director-General of the World Health
Organization (WHO), speaks during a news conference in Geneva, Switzerland,
December 20, 2021. REUTERS/Denis Balibouse Purchase Licensing Rights, opens new
tab
 * Companies

 * Pfizer Inc
   Follow

LONDON, Sept 23 (Reuters) - If rich nations think the pandemic is over, they
should help lower-income countries reach that point too, a senior World Health
Organization official told Reuters.
In an interview, WHO senior adviser Bruce Aylward warned that richer nations
must not step back from tackling COVID-19 as a global problem now, ahead of
future potential waves of infection.
In the last few weeks, WHO Director General Tedros Adhanom Ghebreyesus said the
end of the pandemic was in sight, and U.S President Joe Biden said the pandemic
was over.
Advertisement · Scroll to continue

"When I hear them say, 'Well, we're so comfortable here,' it's like, 'Great, now
you can really help us get the rest of the world done'," said Aylward.
Aylward said that the group he co-ordinates, which focuses on equitable access
to COVID-19 vaccines, treatments and tests worldwide, is not yet ready to move
out of the emergency phase of tackling the pandemic and that countries need to
be ready and have treatments in place for any further waves of infection.
Advertisement · Scroll to continue

"If you go to sleep right now and this wave hits us in three months... God -
blood on your hands," he said.
He also stressed that Biden had a point domestically as the United States has
good access to all COVID tools. It has also not cut its global commitment to
fighting COVID, he added.
Aylward co-ordinates the ACT-Accelerator, a partnership between WHO and other
global health bodies to help poorer countries access COVID-19 tools. The effort,
which includes the vaccine-focused COVAX, has reached billions of people
worldwide but has faced criticism for not acting quickly enough. There had been
some speculation that the effort may wind up this autumn, but Aylward said it
was simply changing its focus as the pandemic changes.

Over the next six months, the partnership will aim particularly at delivering
vaccines to the roughly one quarter of the world's health care workers and
elderly who have still not had a shot, as well as on improving access to
test-and-treat particularly with Pfizer's Paxlovid, he said.
It will also look to the future as COVID is "here to stay", and unless systems
are put in place, support will collapse once other industrialised nations also
think the pandemic is over, said Aylward.

The initiative already has an $11 billion gap in its budget, with most of its
available $5.7 billion in funding pledged towards vaccines rather than tests or
treatments.

Keep up with the latest medical breakthroughs and healthcare trends with the
Reuters Health Rounds newsletter. Sign up here.

Reporting by Jennifer Rigby; Editing by Hugh Lawson

Our Standards: The Thomson Reuters Trust Principles., opens new tab

 * Suggested Topics:
 * Healthcare & Pharmaceuticals
 * COVID-19

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

Purchase Licensing Rights
Jennifer Rigby

Thomson Reuters

Jen is the Global Health Correspondent at Reuters, covering everything from
pandemics to the rise of obesity worldwide. Since joining the news agency in
2022, her award-winning work includes coverage of gender-affirming care for
adolescents in the UK and a global investigation with colleagues into how
contaminated cough syrup killed hundreds of children in Africa and Asia. She
previously worked at the Telegraph newspaper and Channel 4 News in the UK, and
spent time as a freelancer in Myanmar and the Czech Republic.

 * Email
 * X


READ NEXT

 * Healthcare & PharmaceuticalscategoryHealthcare industry rethinks risk after
   murder of UnitedHealth exec
 * WorldcategoryKiller of UnitedHealth's Thompson still at large amid manhunt in
   New York
 * Healthcare & PharmaceuticalscategoryFDA chief defends work on obesity, food
   to US Senate as agency awaits fierce critic RFK Jr
 * Healthcare & PharmaceuticalscategoryLilly invests $3 billion to expand
   Wisconsin plant as obesity drug demand soars
 * Healthcare & PharmaceuticalscategoryThirteen children die in Mexico from
   possible IV bag contamination
 * Healthcare & PharmaceuticalscategoryNovo Nordisk to cut US list prices of two
   insulin products by more than 70%




BUSINESS


 * AIRBUS DELIVERS 84 PLANES IN NOVEMBER
   
   Aerospace & Defensecategory · December 5, 2024 · 9:54 PM HST · 15 min ago
   
   Airbus delivered 84 planes in November as the planemaker moved back towards
   end-year targets after a downturn over the summer.

 * EnergycategoryOil prices dip as extended OPEC+ supply cuts highlight weak
   demand9:41 PM HST · Updated 27 min ago
 * Sustainable Finance & ReportingcategoryUK homebuilder Berkeley cautious on
   near-term demand after HY profit fall9:23 PM HST · Updated an hour ago
 * ANALYSISGas price shock set to add to Europe's industrial pain9:03 PM HST
 * categoryUK 'will think carefully' on retaliating if hit by Trump tariffs,
   business minister tells FT8:28 PM HST




SITE INDEX


LATEST

 * Home
 * Authors
 * Topic Sitemap
 * Archive
 * Article Sitemap


BROWSE

 * World
 * Business
 * Markets
 * Sustainability
 * Legal
 * Breakingviews
 * Technology
 * Investigations
 * Sports
 * Science
 * Lifestyle


MEDIA

 * 
   Videos
 * 
   Pictures
 * 
   Graphics
 * 
   Podcasts


ABOUT REUTERS

 * About Reuters, opens new tab
 * Advertise with Us, opens new tab
 * Careers, opens new tab
 * Reuters News Agency, opens new tab
 * Brand Attribution Guidelines, opens new tab
 * Reuters and AI, opens new tab
 * Reuters Leadership, opens new tab
 * Reuters Fact Check
 * Reuters Diversity Report, opens new tab


STAY INFORMED

 * Download the App (iOS), opens new tab
 * Download the App (Android), opens new tab
 * Newsletters


INFORMATION YOU CAN TRUST

Reuters, the news and media division of Thomson Reuters, is the world’s largest
multimedia news provider, reaching billions of people worldwide every day.
Reuters provides business, financial, national and international news to
professionals via desktop terminals, the world's media organizations, industry
events and directly to consumers.


FOLLOW US

 * X
 * Facebook
 * Instagram
 * Youtube
 * Linkedin


THOMSON REUTERS PRODUCTS

 * WESTLAW, OPENS NEW TAB
   
   BUILD THE STRONGEST ARGUMENT RELYING ON AUTHORITATIVE CONTENT,
   ATTORNEY-EDITOR EXPERTISE, AND INDUSTRY DEFINING TECHNOLOGY.

 * ONESOURCE, OPENS NEW TAB
   
   THE MOST COMPREHENSIVE SOLUTION TO MANAGE ALL YOUR COMPLEX AND EVER-EXPANDING
   TAX AND COMPLIANCE NEEDS.

 * CHECKPOINT, OPENS NEW TAB
   
   THE INDUSTRY LEADER FOR ONLINE INFORMATION FOR TAX, ACCOUNTING AND FINANCE
   PROFESSIONALS.


LSEG PRODUCTS

 * WORKSPACE, OPENS NEW TAB
   
   ACCESS UNMATCHED FINANCIAL DATA, NEWS AND CONTENT IN A HIGHLY-CUSTOMISED
   WORKFLOW EXPERIENCE ON DESKTOP, WEB AND MOBILE.

 * DATA CATALOGUE, OPENS NEW TAB
   
   BROWSE AN UNRIVALLED PORTFOLIO OF REAL-TIME AND HISTORICAL MARKET DATA AND
   INSIGHTS FROM WORLDWIDE SOURCES AND EXPERTS.

 * WORLD-CHECK, OPENS NEW TAB
   
   SCREEN FOR HEIGHTENED RISK INDIVIDUAL AND ENTITIES GLOBALLY TO HELP UNCOVER
   HIDDEN RISKS IN BUSINESS RELATIONSHIPS AND HUMAN NETWORKS.

 * Advertise With Us, opens new tab
 * Advertising Guidelines
 * Purchase Licensing Rights, opens new tab

 * Cookies, opens new tab
 * Terms of Use
 * Privacy, opens new tab
 * Digital Accessibility, opens new tab
 * Corrections
 * Site Feedback, opens new tab

All quotes delayed a minimum of 15 minutes. See here for a complete list of
exchanges and delays.

© 2024 Reuters. All rights reserved